Does Dr. IRINA ALEKSEYEVA have financial conflicts of interest?

Dr. IRINA ALEKSEYEVA (M.D.) has received a total of $1,154 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,154 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. IRINA ALEKSEYEVA?

According to CMS Open Payments data, Dr. IRINA ALEKSEYEVA received funding from SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US ($341), JANSSEN BIOTECH ($258), and TAKEDA PHARMACEUTICALS U.S.A ($227).

Does Dr. IRINA ALEKSEYEVA receive research grants or speaking fees?

Dr. IRINA ALEKSEYEVA has received $1,154 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. IRINA ALEKSEYEVA

M.D.Real-Time Hydrated

Specialty: Anesthesiology

Practice Location: FORT LEE, NJ 07024

NPI Number: 1093719478

LIFETIME INDUSTRY VALUE

$1,154

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALEKSEYEVA is a verified Anesthesiology practitioner based in FORT LEE, NJ.

Between 2021 and 2024, Dr. ALEKSEYEVA had an overall industry promotional and research financial footprint of $1,154 as recorded in the federal CMS Open Payments database.

$1,154 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALEKSEYEVA's primary funding source is SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, which accounts for $341 (representing 29.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US

Rank 1

$341

29.5%

JANSSEN BIOTECH

Rank 2

$258

22.3%

TAKEDA PHARMACEUTICALS U.S.A

Rank 3

$227

19.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.